Skip to main content

Security report for takeda.com

Takeda Pharmaceutical Company Limited · Healthcare · Japan

Medium risk. 4 critical or high findings in Security headers, SSL/TLS and 1 other check.

Security score

74/100

Risk levelMedium

0–100, higher is better. How it is calculated

Takeda Pharmaceutical Company Limited is a globally recognized biopharmaceutical enterprise focused on patient-centric research and development. The company operates at a large scale within the healthcare industry, providing pharmaceutical products, conducting clinical trials, and emphasizing corporate responsibility and sustainability. Their website reflects a professional and comprehensive digital presence, targeting healthcare professionals, patients, investors, and partners worldwide. The business model centers on innovation and global pharmaceutical manufacturing and supply. Technically, the website leverages modern frameworks such as Next.js and React, hosted on Vercel, ensuring fast performance and excellent mobile optimization. The use of analytics tools like Matomo and Google Tag Manager indicates a mature approach to user data collection and marketing insights. The site is well-structured with good SEO and accessibility features, supporting a positive user experience. From a security perspective, the site enforces HTTPS, employs multiple security headers, and integrates a cookie consent mechanism compliant with GDPR. No critical vulnerabilities or exposed sensitive data were detected. However, the absence of a dedicated security policy or vulnerability disclosure page suggests room for improvement in transparency and incident response readiness. Overall, the website presents a low-risk profile with strong business credibility and technical maturity. The main limitation is the lack of WHOIS data, which is unusual but does not detract significantly from the trustworthiness given the company's global reputation and professional web presence. Strategic recommendations include publishing explicit security policies, incident response contacts, and vulnerability disclosure information to enhance trust and compliance.

Scanned

NIS2 and GDPR posture

GDPR outside view
88/ 100 · Low
Checks completed
7of 7

NIS2 Art. 21(2)

  1. (a) Risk analysis and security policies: Not visible from outside
  2. (b) Incident handling: One indicator
  3. (c) Business continuity, backups and crisis management: Not visible from outside
  4. (d) Supply chain security: Not visible from outside
  5. (e) Secure acquisition, development and maintenance, including vulnerability handling: Partly checked
  6. (f) Assessing the effectiveness of security measures: Not visible from outside
  7. (g) Cyber hygiene and security training: Not visible from outside
  8. (h) Cryptography and encryption: Partly checked
  9. (i) HR security, access control and asset management: One indicator
  10. (j) Multi-factor authentication and secured communications: Not visible from outside

This scan rated NIS2 with an earlier keyword method that is no longer shown; rescan for the per-article view. Risk management, continuity, supply chain, training, MFA, management oversight (Art. 20) and incident reporting (Art. 23) need internal evidence, and Guard cannot tell whether NIS2 applies to this organisation.

GDPR is indicative only, based on publicly visible signals: Articles 7, 12, 13 and 32 of Regulation (EU) 2016/679 and Article 5(3) of the ePrivacy Directive. Not a certification or legal assessment.

Priority findings

4 findings rated critical or high. Fix these first.

  1. Security headers

    Security headers are instructions your web server sends to every visitor’s browser. Missing ones leave visitors more exposed to attacks such as clickjacking and injected scripts.

    • High

      Missing X-Frame-Options header

      Prevents clickjacking attacks

      What to do: Add "X-Frame-Options: DENY" or "X-Frame-Options: SAMEORIGIN"

    • High

      Missing Content-Security-Policy header

      Controls resources the browser is allowed to load

      What to do: Implement a Content-Security-Policy appropriate for your application

      • ASVS V3.4.3
      • OWASP Secure Headers: OWASP Secure Headers Project recommends Content-Security-Policy: default-src 'self'; form-action 'self'; base-uri 'self'; object-src 'none';…
  2. SSL/TLS

    TLS encrypts the connection and proves the site is really yours. Weak or expiring certificates trigger browser warnings and put traffic at risk.

    • High

      Weak SSL Key Length

      SSL certificate uses 256-bit key, which is considered weak

      What to do: Use at least 2048-bit RSA or 256-bit ECC key

      • CWE-326
      • OWASP A04:2025
      • Mozilla TLS: Mozilla Server Side TLS 6.0 intermediate: rsa_key_size 2048
  3. DNS health

    DNS sends visitors and email to the right servers. Misconfigured records can cause outages or let someone redirect your traffic.

    • High

      Domain Expires Soon

      Domain expires in 24 days

      What to do: Renew domain registration before expiration

Need hands-on remediation? Email guard@offseq.com

Keep watching takeda.com

This scan found 19 issues across 6 checks. Monitoring re-runs those checks daily, emails you when something material changes and records each fix, so you can show progress.

Daily monitoring

Recommended

€25per month

  • TLS certificates and expiry
  • DNS records
  • SPF, DKIM and DMARC
  • Security headers
  • GDPR and NIS2 posture
  • Exposed services
  • Third-party trackers
  • Security score drift

Email alerts on material changes and an exportable JSON history of every change.

Billed monthly to your card. Cancel anytime. See sample alerts.

Full report

€39.90one-time

  • The complete analysis as a PDF you can cite
  • Email delivery with an unlock code
  • Lifetime access to this report

Prices incl. 21% VAT. Secure checkout by Mollie; sold by SEQ SIA, Latvia.

Results by check

Each check with its score, findings and the evidence it collected.

How this score is calculated

The security score runs 0–100, higher is better. It is the plain average of the security checks that completed in this scan, each counted equally. A check that could not run is left out: it counts neither as a pass nor as a fail.

Counted in this score

SSL/TLS
75
Security headers
30
Email security
85
DNS health
65
Network security
100
GDPR outside view
88
Average
74

Not counted

  • NIS2 outside view: Re-weights evidence from the TLS, email, DNS, network and hygiene checks, so counting it would count that evidence twice. Shown on its own.
  • OffSeq Observations: An AI reading of the site, useful context but not reproducible evidence. Shown on its own.

Findings that cap the score at 49

Each of these is serious on its own, so while any is present the site cannot rate better than high risk, however good the other checks are.

  • The certificate is not trusted by browsers
  • The website is not served over HTTPS
  • A database, remote desktop, file-sharing or Telnet service is reachable from the internet
  • The page loads a script from a compromised source
  • The domain registration has expired
  • SPF authorises every server to send mail as the domain

Partial scans

When the site blocks Guard or most checks cannot run, the score covers only the checks that ran (usually DNS and email), is capped at 75 and is shown as partial, without a risk level.

Risk levels

  • Critical0–25
  • High26–49
  • Medium50–75
  • Low76–100

Technical appendix

Business context, site observations and technical notes gathered during the scan, and the standards behind each reference.

Business context

Business profile

Takeda holds a strong market position as a leading global pharmaceutical company with a focus on R&D-driven innovation. Their competitive advantages include a broad product pipeline, commitment to sustainability, and transparent corporate governance. Revenue streams are primarily from pharmaceutical product sales and clinical research partnerships. The target customer segments include healthcare providers, patients, and investors. Growth indicators are supported by extensive corporate responsibility initiatives and global outreach. The partnership ecosystem includes social media and analytics providers but no explicit business partners were identified in the domain data. Operationally, the company maintains a consistent and professional digital footprint aligned with its industry stature.

Security posture

The website demonstrates a mature security posture with enforced HTTPS, comprehensive security headers, and GDPR-compliant cookie consent. No exposed credentials or vulnerable libraries were found in the analyzed content. However, the absence of a published security policy and incident response contact details limits transparency. There is no evidence of a vulnerability disclosure program or security.txt file, which are best practices for large enterprises. Compliance with privacy regulations appears strong, but incident response readiness and public security communication could be enhanced. Overall, the security maturity is high but could benefit from improved documentation and disclosure.

Recommendations

  1. Publish a dedicated security policy page outlining security practices and commitments.
  2. Provide clear incident response contact information, including security@ or abuse@ email addresses.
  3. Implement and publish a vulnerability disclosure policy or security.txt file to encourage responsible reporting.
  4. Enhance accessibility features to meet or exceed WCAG standards for inclusivity.
  5. Regularly audit and update third-party scripts and analytics tools to mitigate potential vulnerabilities.

Contact details published on the site

Addresses
Legal name
Takeda Pharmaceutical Company Limited
Site observations

Automated reading of the public site. Ratings are indicative.

Business

Company
Takeda Pharmaceutical Company Limited
Description
Takeda is a patient-focused, R&D-driven global biopharmaceutical company committed to bringing Better Health and a Brighter Future.
Key services
Pharmaceutical research and development, Manufacturing and supply of medicines, Clinical trials
Content quality
excellent
Branding
consistent

Technology

Stack
React, Next.js, Vercel Analytics, Matomo Analytics, Google Tag Manager
Frameworks
Next.js
Platforms
Vercel
Performance
fast
Mobile
excellent
Accessibility
good
SEO
good

Security

Observed score
90/100
Good practices seen
  • HTTPS enforced
  • Use of security headers
  • No exposed sensitive data in HTML
  • Secure cookie consent mechanism

Analytics and tracking

Services
Matomo, Google Tag Manager
Tracking level
moderate
Privacy practices
good

Advertising

Tracking pixels
Matomo
Transparency
good

Site quality

Design
excellent
User experience
excellent
Content relevance
excellent
Navigation
excellent
Professionalism
excellent
Trustworthiness
high

Key observations

  1. Website is fully accessible with no blocking or WAF challenge.
  2. Content is comprehensive, professional, and well-structured.
  3. Strong focus on corporate responsibility and transparency.
  4. Use of modern web technologies and analytics tools.
  5. No signs of suspicious or malicious activity.
  6. WHOIS data unavailable, which is unusual but not necessarily suspicious given the corporate nature.
Technical notes

Notes

The website is built on a modern technology stack featuring React and Next.js, hosted on Vercel, which supports fast loading times and excellent mobile responsiveness. The use of server-side rendering and optimized image loading contributes to performance. Analytics integration with Matomo and Google Tag Manager indicates a sophisticated approach to data collection and marketing. The site employs comprehensive meta tags and structured data (JSON-LD) for SEO benefits. Technical debt appears minimal, with no broken elements or errors detected. Opportunities for modernization include expanding accessibility features and formalizing security documentation to align with enterprise best practices.
Standards and sources

Reference chips under each finding point to the standard, regulation or specification the finding relates to. They are taken from the official datasets below and mapped conservatively: a finding with no defensible link shows none. NIS2 and GDPR references mark where a finding is relevant evidence, not a compliance verdict. Implementing Regulation (EU) 2024/2690 binds digital infrastructure and digital service providers; for other entities it is the most detailed public reading of the Article 21 measures. WCAG, EN 301 549, European Accessibility Act and Web Accessibility Directive references name the requirement an automated accessibility rule relates to; they are not a conformance verdict.

Retrieved 2026-10-25

Earlier scans of this domain

  1. 76/100 +30Low26 findingsView report
  2. 46/100High26 findingsView report
Reviews of this site

Share your experience with takeda.com. Every review is verified by email and published after moderation.

Overall rating
Select a rating
4000 characters remaining

We’ll email you to confirm your review and keep your details private.

Community rating

No published reviews yet. Be the first to review takeda.com.

Feedback on this report

Rate this report, add an optional comment, and tell us if you want a security specialist to follow up.

Overall report quality
Select a rating
2000 characters remaining

We only use your feedback to improve Guard reports. Contact details are never shared.